These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38826986)

  • 21. Relationship between serum growth differentiation factor 15, fibroblast growth factor-23 and risk of atrial fibrillation: A systematic review and meta-analysis.
    Tan Z; Song T; Huang S; Liu M; Ma J; Zhang J; Yu P; Liu X
    Front Cardiovasc Med; 2022; 9():899667. PubMed ID: 35990956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Growth Differentiation Factor 15 with Arterial Stiffness and Endothelial Function in Subpopulations of Patients with Coronary Artery Disease: A Proof-of-Concept Study.
    Mourouzis K; Siasos G; Bozini N; Oikonomou E; Zaromitidou M; Tsigkou V; Kokkou E; Bletsa E; Stampouloglou P; Vavuranakis M; Tousoulis D
    Recent Adv Inflamm Allergy Drug Discov; 2022; 16(2):107-115. PubMed ID: 36336806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of Growth differentiation factors 15 in Acute heart failure patients with preserved ejection fraction.
    Yin D; Yan X; Bai X; Tian A; Gao Y; Li J
    ESC Heart Fail; 2023 Apr; 10(2):1025-1034. PubMed ID: 36519216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of Plasma GDF-15 for Diagnosis and Prognosis Assessment of ICU-Acquired Weakness in Mechanically Ventilated Patients: Prospective Observational Study.
    Xie Y; Liu S; Zheng H; Cao L; Liu K; Li X
    Biomed Res Int; 2020; 2020():3630568. PubMed ID: 32104689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study.
    Clark BJ; Bull TM; Benson AB; Stream AR; Macht M; Gaydos J; Meadows C; Burnham EL; Moss M;
    Crit Care; 2013 May; 17(3):R92. PubMed ID: 23706007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19.
    Alserawan L; Peñacoba P; Orozco Echevarría SE; Castillo D; Ortiz E; Martínez-Martínez L; Moga Naranjo E; Domingo P; Castellví I; Juárez C; Mariscal A
    Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating growth differentiation factor-15 as a novel biomarker in heart transplant.
    Tokavanich N; Sinphurmsukskul S; Kongruttanachok N; Thammanatsakul K; Sritangsirikul S; Ariyachaipanich A; Ongcharit P; Siwamogsatham S; Boonyaratavej S; Puwanant S
    ESC Heart Fail; 2021 Aug; 8(4):3279-3285. PubMed ID: 34110100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of FGF-21 and GDF-15 for the diagnosis of mitochondrial disorders: A meta-analysis.
    Lin Y; Ji K; Ma X; Liu S; Li W; Zhao Y; Yan C
    Ann Clin Transl Neurol; 2020 Jul; 7(7):1204-1213. PubMed ID: 32585080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GDF-15 Levels and Other Laboratory Findings as Predictors of COVID-19 Severity and Mortality: A Pilot Study.
    Švitek L; Lišnjić D; Grubišić B; Zlosa M; Schönberger E; Vlahović Vlašić N; Smajić P; Sabadi D; Rolić T; Kralik K; Mandić S
    Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prognostic Value of Lung Injury and Fibrosis Markers, KL-6, TGF-β1, FGF-2 in COVID-19 Patients.
    Karadeniz H; Avanoğlu Güler A; Özger HS; Yıldız PA; Erbaş G; Bozdayı G; Deveci Bulut T; Gülbahar Ö; Yapar D; Küçük H; Öztürk MA; Tufan A
    Biomark Insights; 2022; 17():11772719221135443. PubMed ID: 36380740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential Biomarkers of Mitochondrial Dysfunction Associated with COVID-19 Infection.
    Turton N; Millichap L; Hargreaves IP
    Adv Exp Med Biol; 2023; 1412():211-224. PubMed ID: 37378769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease.
    Wang X; Chen LL; Zhang Q
    Cardiovasc Ther; 2016 Jun; 34(3):138-43. PubMed ID: 26996787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19.
    Ajaz S; McPhail MJ; Singh KK; Mujib S; Trovato FM; Napoli S; Agarwal K
    Am J Physiol Cell Physiol; 2021 Jan; 320(1):C57-C65. PubMed ID: 33151090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GDF-15, a mitochondrial disease biomarker, is associated with the severity of multiple sclerosis.
    Nohara S; Ishii A; Yamamoto F; Yanagiha K; Moriyama T; Tozaka N; Miyake Z; Yatsuga S; Koga Y; Hosaka T; Terada M; Yamaguchi T; Aizawa S; Mamada N; Tsuji H; Tomidokoro Y; Nakamagoe K; Ishii K; Watanabe M; Tamaoka A
    J Neurol Sci; 2019 Oct; 405():116429. PubMed ID: 31476622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum AXL is a potential molecular marker for predicting COVID-19 progression.
    You J; Huang R; Zhong R; Shen J; Huang S; Chen J; Chen F; Kang Y; Chen L
    Front Immunol; 2024; 15():1394429. PubMed ID: 38799467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth Differentiation Factor-15 (GDF-15) as a Predictor of Major Adverse Cardiac Event in Acute Myocardial Infarction Patients.
    Tridamayanti A; Wasyanto T; Yasa' A
    Acta Med Indones; 2022 Apr; 54(2):238-246. PubMed ID: 35818647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth Differentiation Factor-15 Predicts Mortality and Heart Failure Exacerbation But Not Ventricular Arrhythmias in Patients With Cardiomyopathy.
    Binder MS; Yanek LR; Yang W; Butcher B; Norgard S; Marine JE; Kolandaivelu A; Chrispin J; Fedarko NS; Calkins H; O'Rourke B; Wu KC; Tomaselli GF; Barth AS
    J Am Heart Assoc; 2023 Feb; 12(3):e8023. PubMed ID: 36718879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
    Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
    PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.